Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001193125-26-129156

Options or other derivatives

  • Chief Executive Officer acquired 750,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Kirn David · Chief Executive Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-25 Grant or award : show line 1 in the form Stock Option (Right to Buy) +750,000 750,000 D
Loading xslF345X06/ownership.xml…